The rising interest in GLP-1 agonists for diabetes has sparked a discussion about delivery routes : patches versus capsules. Typically, GLP-1 inyecciones para bajar de peso therapies were solely available in oral form, but the development of patches presents a alternative choice . Transdermal systems might benefit individuals with challenges swallo